Advertisement
If you have a new account but are having problems posting or verifying your account, please email us on hello@boards.ie for help. Thanks :)
Hello all! Please ensure that you are posting a new thread or question in the appropriate forum. The Feedback forum is overwhelmed with questions that are having to be moved elsewhere. If you need help to verify your account contact hello@boards.ie
Hi there,
There is an issue with role permissions that is being worked on at the moment.
If you are having trouble with access or permissions on regional forums please post here to get access: https://www.boards.ie/discussion/2058365403/you-do-not-have-permission-for-that#latest

Glaxo Settles Cases With U.S. for $3 Billion

  • 06-11-2011 8:01pm
    #1
    boardswalker
    Registered Users, Registered Users 2 Posts: 460 ✭✭


    From New York Times, 3 Nov 11

    The British drug company GlaxoSmithKline said Thursday that it had agreed to pay $3 billion to settle United States government civil and criminal investigations into its sales practices for numerous drugs.

    ......

    The cases against GlaxoSmithKline include illegal marketing of Avandia, a diabetes drug that was severely restricted last year after it was linked to heart risks. Federal prosecutors said the company had paid doctors and manipulated medical research to promote the drug.


Comments

  • #2
    imported_guy
    Closed Accounts Posts: 1,141 ✭✭✭imported_guy


    nothing new, depuy's ASR hip implant recall is another example, settled with patients etc for some unimaginable amount that doesnt cross my mind right now also http://www.rotlaw.com/updates/depuys-consultant-compensation-tops-50-million-in-2009/ http://need-health.com/womens-health-166/content-9183.html this article names other companies like zimmer and stryker too who pay under the table to docs


  • #3
    boardswalker
    Registered Users, Registered Users 2 Posts: 460 ✭✭boardswalker


    From the BBC news website:

    US drugs firm Merck & Co has agreed to pay almost $1bn (£640m) to settle criminal and civil charges arising from the marketing of one of its drugs, the US Department of Justice has said.

    The company will pay a $322m criminal fine and $628m to settle civil charges regarding the promotion of the painkiller Vioxx.

    The department said Merck & Co promoted the drug for rheumatoid arthritis before it was officially approved.

    The drug was withdrawn in 2004.

    Merck & Co said the civil settlement did not constitute an admission of liability or wrongdoing.

    "We believe that Merck acted responsibly and in good faith in connection with the conduct at issue in these civil settlement agreements, including activities concerning the safety profile of Vioxx," said the company's Bruce Kuhlik.

    In October last year, Merck & Co said it would be setting aside $950m to cover the cost of the settlement.

    In 2007, the company paid $4.85bn to settle thousands of Vioxx-related lawsuits.

    A study found the drug could increase the risk of heart attacks and strokes.


Advertisement